VerImmune
Entity

  • VerImmune

    Created in 2019
  • BETA

    Up & running (A)
    Existing signals show a regular activity

  • Social networks

    966

  • Activities

    deeptech biotech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    Washington, DC, USA

    Washington

    United States of America

  • Employees

    Scale: 2-10

    Estimated: 12

  • Engaged corporates

    1
    0 0

  • Added in Motherbase

    1 month, 2 weeks ago
Description
  • Value proposition

    Redirecting Immune Memory from Pathogens or Childhood Vaccines to Target Cancer

    VerImmune is advancing Anti-tumor Immune Redirection (AIR):
    A Breakthrough Therapy that Redirects Pre-Existing Immune Memory
    from Childhood Vaccination or Infection to Fight Cancer

Corporate interactions BETA
Corporate TypeTweets Articles
Amgen
Amgen
Biotechnology, Biotechnology Research
Amgen
Biotechnology, Biotechnology Research 		Other

1 Mar 2025


Similar entities
Last news
Show all articles
Social network dynamics